Evaluation of Diagnostic Performance of VisioCyt® Test, in Case of Suspicion of Urothelial Bladder Tumors
NCT02966691
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
1360
Enrollment
OTHER
Sponsor class
Conditions
Bladder Cancer
Interventions
OTHER:
VisioCyt® diagnostic test
Sponsor
Vitadx
Collaborators
[object Object]
[object Object]